Table 4.

Evaluation of various sets of criteria for AOSD in our series compared to previous series.

Criteria	AOSD, n	Controls, n	Sensitivity, %	Specificity, %	PPV, %	NPV, %	PLR	NLR	Accuracy, %
Our series	70	140
Reginato	36^*	1^†	51.43	99.29	97.30	80.35	72.44	0.49	83.33
Yamaguchi	55^*	12^†	78.57	91.43	82.09	89.51	9.17	0.23	87.14
Cush	43^*	3^†	61.43	97.86	93.48	83.54	28.71	0.39	85.71
Calabro	48^*	7^†	68.57	95.00	87.27	85.81	13.71	0.33	86.19
Fautrel¹⁸	72	130
Yamaguchi	57^*	8^†	79.2	93.8	87.7	89.1			88.6
Yamaguchi¹	53	164
Reginato			51.2	99.2					87.9
Yamagucci	51^*	13^†	96.2	92.1					93.1
Cush			80	96.9					92.8
Calabro			60.9	98.1					88.7

↵* Number of positive patients by the evaluating criteria in the AOSD group.
↵† Number of positive patients by the evaluating criteria in the control group. PPV: positive predictive value; NPV: negative predictive value; PLR: positive likelihood ratio; NLR: negative likelihood ratio.